Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia.
Harris
E
E
Behrens
J
J
Samson
D
D
Rahemtulla
A
A
Russell
N H
NH
Byrne
J L
JL
D058186:Acute Kidney Injury / Q000150:complications*; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications*; D013792:Thalidomide / Q000009:adverse effects*
D020533:Angiogenesis Inhibitors; D013792:Thalidomide